21 min listen
Scouring Genetic Variation within Our Cells for Drug Targets
FromThe Bio Report
ratings:
Length:
26 minutes
Released:
Feb 7, 2024
Format:
Podcast episode
Description
People tend to think of each person having their own unique genome. Quotient Therapeutics is taking an approach to drug discovery based on the reality that from cell to cell within a given individual, there can be trillions of divergent genomes. Changes in cells throughout the body can alter how a cell responds to disease and point to new ways to cure, treat, or prevent conditions. We spoke to Jacob Rubens, president of Quotient, about the company’s platform technology, how it tests genetic mutations at a cellular level, and its efforts to build a pipeline of therapies around the insights it gains.
Released:
Feb 7, 2024
Format:
Podcast episode
Titles in the series (100)
The Forces Bringing Disruptive Change to Healthcare: Scientific breakthroughs, innovations in technology, and the changing use of data are among the forces that are driving disruptive changes to healthcare. A new report from the IMS Institute for Healthcare Informatics highlights a number of these deve... by The Bio Report